El Burai Félix Sausan, Mack Karin
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, Estados Unidos de América,
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, Estados Unidos de América.
Rev Panam Salud Publica. 2014 Oct;36(4):270-6.
Since the late 1990s, the number of opioid analgesic overdose deaths has quadrupled in the United States of America (from 4 030 deaths in 1999 to 16 651 in 2010). The objectives of this article are to provide an overview of the problem of prescription drug overdose in the United States and to discuss actions that could help reduce the problem, with particular attention to the characteristics of prescription drug monitoring programs (PDMPs). These programs consist of state-level databases that monitor controlled substances. The information compiled in the databases is at the disposal of authorized persons (e.g., physicians, pharmacists, and other health-care providers) and may be used only for professional purposes. Suppliers can use such information to prevent interaction with other drugs or therapeutic duplication, or to identify drug-search behavior. Law enforcement agencies can use these programs to identify improper drug prescription or dispensing patterns, or drug diversion.
自20世纪90年代末以来，美国阿片类镇痛药物过量致死人数增长了两倍（从1999年的4030人死亡增至2010年的16651人）。本文旨在概述美国处方药过量问题，并讨论有助于减少该问题的行动，尤其关注处方药监测计划（PDMPs）的特点。这些计划由监测管制药品的州级数据库组成。数据库中汇编的信息可供授权人员（如医生、药剂师和其他医疗保健提供者）使用，且仅可用于专业目的。供应商可利用此类信息防止与其他药物相互作用或治疗重复，或识别药物搜索行为。执法机构可利用这些计划识别不当的药物处方或配药模式，或药物转移情况。
